Although the role of AMPK in the development of cancer stem cells has not been established, there are recent reports demonstrating that HepG2 cells transfected with CD90 have higher expression of CD133 and lower levels of AMPK phosphorylation (Chen et al., 2015b), which is in line with our results. Here, PRKAA1 is linked to cancer.